2029, Health and Patients - Chiropractic Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2029

Health

Patients

AdventHealth investing $1 billion into its Orlando campus

OrthoSpineNews

MAY 16, 2025

Funds will be used for a new 14-story patient tower, updated technologies and additional residency and fellowship programs. May 16, 2025 – Jeff Lagasse , Editor AdventHealth is putting more than $1 billion into its Orlando campus, with the funds earmarked for construction of a new 14-story patient tower as well as expanded services.

Health

Health Patients

OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment

OrthoSpineNews

JANUARY 29, 2025

The designation covers the use of the therapeutic medical device to treat patients who continue to experience knee pain or impairment following a meniscus surgery, which impacts approximately 250,000 Americans annually. ” OrthoPreserve hopes to launch their Pilot clinical trial in 2026, while aiming for potential FDA approval by 2029.

Knee Pain

Knee Pain Treatment Joints Health

AdventHealth investing $1 billion into its Orlando campus

OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment

Stay Connected